Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3044% above fair value
$27.20+1.54 (+6.00%)
Close on Nov 18, 2026Market cap $2.03BP/E –Yield –
Schrodinger net income
Net income is the profit left for shareholders after every expense, interest and tax.
Schrodinger's net income for the twelve months ending Jun 30, 2026 was -$54.34M. For fiscal 2025 it was -$103.27M. The highest annual figure on record is $40.72M in fiscal 2023.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$103.27M | – |
| FY2024 | Dec 31, 2024 | -$187.12M | -559.5% |
| FY2023 | Dec 31, 2023 | $40.72M | – |
| FY2022 | Dec 31, 2022 | -$149.19M | – |
| FY2021 | Dec 31, 2021 | -$100.39M | – |
| FY2020 | Dec 31, 2020 | -$24.46M | – |
| FY2019 | Dec 31, 2019 | -$24.57M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.98M | – |
| Q1 FY2026 | Mar 31, 2026 | -$60.03M | – |
| Q4 FY2025 | Dec 31, 2025 | $32.51M | – |
| Q3 FY2025 | Sep 30, 2025 | -$32.80M | – |
| Q2 FY2025 | Jun 30, 2025 | -$43.17M | – |
| Q1 FY2025 | Mar 31, 2025 | -$59.81M | – |
| Q4 FY2024 | Dec 31, 2024 | -$40.22M | – |
| Q3 FY2024 | Sep 30, 2024 | -$38.14M | – |
| Q2 FY2024 | Jun 30, 2024 | -$54.05M | -1363.4% |
| Q1 FY2024 | Mar 31, 2024 | -$54.72M | -142.4% |
| Q4 FY2023 | Dec 31, 2023 | -$30.67M | – |
| Q3 FY2023 | Sep 30, 2023 | -$62.02M | – |
| Q2 FY2023 | Jun 30, 2023 | $4.28M | – |
| Q1 FY2023 | Mar 31, 2023 | $129.14M | – |
| Q4 FY2022 | Dec 31, 2022 | -$27.21M | – |
| Q3 FY2022 | Sep 30, 2022 | -$39.85M | – |
| Q2 FY2022 | Jun 30, 2022 | -$47.69M | – |
| Q1 FY2022 | Mar 31, 2022 | -$34.44M | – |
| Q4 FY2021 | Dec 31, 2021 | -$30.71M | – |
| Q3 FY2021 | Sep 30, 2021 | -$35.01M | -1008.8% |
| Q2 FY2021 | Jun 30, 2021 | -$34.64M | – |
| Q1 FY2021 | Mar 31, 2021 | -$29.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$11.14M | – |
| Q3 FY2020 | Sep 30, 2020 | $3.85M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.35M | – |
| Q1 FY2020 | Mar 31, 2020 | -$13.83M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.77M | – |
| Q3 FY2019 | Sep 30, 2019 | -$11.51M | – |
| Q2 FY2019 | Jun 30, 2019 | -$500.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.79M | – |
See a number that looks wrong?